Co‐expression of human calreticulin significantly improves the production of HIV gp140 and other viral glycoproteins in plants
Open Access
- 24 February 2020
- journal article
- research article
- Published by Wiley in Plant Biotechnology Journal
- Vol. 18 (10), 2109-2117
- https://doi.org/10.1111/pbi.13369
Abstract
Plant molecular farming (PMF) is rapidly gaining traction as a viable alternative to the currently accepted paradigm of producing biologics. While the platform is potentially cheaper and more scalable than conventional manufacturing systems, expression yields and appropriate post‐translational modifications along the plant secretory pathway remain a challenge for certain proteins. Viral fusion glycoproteins in particular are often expressed at low yields in plants and, in some cases, may not be appropriately processed. Recently, however, transiently or stably engineering the host plant has shown promise as a strategy for producing heterologous proteins with more complex maturation requirements. In this study we investigated the co‐expression of a suite of human chaperones to improve the production of a human immunodeficiency virus (HIV) type 1 soluble gp140 vaccine candidate in Nicotiana benthamiana plants. The co‐expression of calreticulin (CRT) resulted in a dramatic increase in Env expression and ameliorated the endoplasmic reticulum (ER) stress response ‐ as evidenced by lower transcript abundance of representative stress‐responsive genes. The co‐expression of CRT similarly improved accumulation of glycoproteins from Epstein‐Barr virus (EBV), Rift Valley fever virus (RVFV) and chikungunya virus (CHIKV), suggesting that the endogenous chaperone machinery may impose a bottleneck for their production. We subsequently successfully combined the co‐expression of human CRT with the transient expression of human furin, to enable the production of an appropriately cleaved HIV gp140 antigen. These transient plant host engineering strategies are a promising approach for the production of high yields of appropriately processed and cleaved viral glycoproteins.Keywords
Funding Information
- Biotechnology and Biological Sciences Research Council (BBS/E/J/000PR9794)
- National Institute for Health Research (16/107/04)
- John Innes Foundation
- Harry Crossley Foundation
- South African Medical Research Council
This publication has 64 references indexed in Scilit:
- A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing AntibodiesPLoS Pathogens, 2013
- Viral envelope glycoprotein processing by proprotein convertasesAntiviral Research, 2013
- Acid-Activated Structural Reorganization of the Rift Valley Fever Virus Gc Fusion ProteinJournal of Virology, 2012
- Evaluation of recombinant E2 protein-based and whole-virus inactivated candidate vaccines against chikungunya virusVaccine, 2012
- Structural Basis of Cyclophilin B Binding by the Calnexin/Calreticulin P-domainOnline Journal of Public Health Informatics, 2010
- pEAQ: versatile expression vectors for easy and quick transient expression of heterologous proteins in plantsPlant Biotechnology Journal, 2009
- Plant-produced vaccines: promise and realityDrug Discovery Today, 2009
- Substrate Specificity of the Oxidoreductase ERp57 Is Determined Primarily by Its Interaction with Calnexin and CalreticulinOnline Journal of Public Health Informatics, 2009
- Optimization of human papillomavirus type 16 (HPV-16) L1 expression in plants: comparison of the suitability of different HPV-16 L1 gene variants and different cell-compartment localizationJournal of General Virology, 2007
- Nascent Lipidated Apolipoprotein B Is Transported to the Golgi as an Incompletely Folded Intermediate as Probed by Its Association with Network of Endoplasmic Reticulum Molecular Chaperones, GRP94, ERp72, BiP, Calreticulin, and Cyclophilin BOnline Journal of Public Health Informatics, 2003